Prescription drug · ANDA
ziprasidone mesylate NDC 70518-4755
Ziprasidone mesylate 20 mg/mL · Injection, Powder, Lyophilized, For solution · Intramuscular · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4755-0 | 7051847550070518475500 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70518-4755-0) / 1 mL in 1 VIAL, SINGLE-DOSE (70518-4755-1)Marketed from Sep 17, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ziprasidone mesylate
- Generic name (nonproprietary)
- ziprasidone mesylate
- Active ingredients
- Ziprasidone mesylate — 20 mg/mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intramuscular
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211908
- Marketing start
- Listing expires
- Identifiers
- Product ID 70518-4755_5bb2ae5f-22ec-fdb1-e063-6294a90a6f05SPL ID 5bb2ae5f-22ec-fdb1-e063-6294a90a6f05
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470518475500followed by a unit qualifier and the quantityPackage 70518-4755-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70518-4755
- What is NDC 70518-4755?
- 70518-4755 is the product NDC for ziprasidone mesylate, Ziprasidone mesylate 20 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- ziprasidone mesylate.
- What is the active ingredient?
- Ziprasidone mesylate.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for ziprasidone mesylate?
- 7 other product NDCs are listed under this name. See all ziprasidone mesylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other ziprasidone mesylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ziprasidone Mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 82449-004 | 82449-0004-0182449-0004-02 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Novadoz Pharmaceuticals LLC | 72205-205 | 72205-0205-07 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Dr.Reddy's Laboratories, Inc. | 43598-061 | 43598-0061-58 |
| Ziprasidone Mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | HF Acquisition Co LLC, DBA HealthFirst | 51662-1564 | 51662-1564-03 |
| Ziprasidone Mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Fosun Pharma USA Inc. | 72266-160 | 72266-0160-10 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Dr.Reddy's Laboratories, Inc. | 43598-848 | 43598-0848-58 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Gland Pharma Limited | 68083-340 | 68083-0340-01 |
Other NDCs under ANDA 211908
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Gland Pharma Limited | 68083-340 |
| Ziprasidone Mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | HF Acquisition Co LLC, DBA HealthFirst | 51662-1564 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Dr.Reddy's Laboratories, Inc. | 43598-061 |
| Ziprasidone Mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Fosun Pharma USA Inc. | 72266-160 |
| Ziprasidone Mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Fosun Pharma USA Inc. | 72266-160 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Dr.Reddy's Laboratories, Inc. | 43598-848 |